- Moderna’s Stock Plummets After Cancer-Vaccine Data Shared on Social Media WSJ
- Moderna, Merck shares fall on eagerly anticipated cancer vaccine results BioPharma Dive
- Merck/Moderna cancer vaccine cuts risk of melanoma death or recurrence by over 40% Reuters
- Moderna sheds about $24 billion as cancer vaccine data triggers ‘sell-the-news’ retreat KSL News
- Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial STAT